Literature DB >> 24530610

Colorectal cancer prevention in Europe: burden of disease and status of screening programs.

E Altobelli1, A Lattanzi2, R Paduano3, G Varassi4, F di Orio5.   

Abstract

Colorectal cancer is a major public health challenge worldwide. In Europe it is the first malignancy in terms of incidence and the second in terms of mortality in both genders. Despite evidence indicating that removal of premalignant and early-stage cancer lesion scan greatly reduce mortality, remarkable differences are still found among countries both in terms of organized screening programs and of the tests used. In 2003 the European Council recommended that priority be given to activation of organized cancer screening programs, and various states have been making significant efforts to adopt effective prevention programs with international quality standards and centralizing screening organization and result evaluation. After a 2008 European Union report on the state of screening program, activation highlighted that little more than 50% (12/22) of Member States had colorectal cancer screening programs, Screening programs have been adopted or earlier pilot projects have been extended nationwide. This paper examines the state of activation and the screening strategies of colorectal cancer screening programs in EU States as of July 2013.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer; Colorectal; EU28; Screening

Mesh:

Year:  2014        PMID: 24530610     DOI: 10.1016/j.ypmed.2014.02.010

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  69 in total

Review 1.  The value of models in informing resource allocation in colorectal cancer screening: the case of The Netherlands.

Authors:  Frank van Hees; Ann G Zauber; Harriët van Veldhuizen; Marie-Louise A Heijnen; Corine Penning; Harry J de Koning; Marjolein van Ballegooijen; Iris Lansdorp-Vogelaar
Journal:  Gut       Date:  2015-06-10       Impact factor: 23.059

2.  Cost-Effectiveness of Personalized Screening for Colorectal Cancer Based on Polygenic Risk and Family History.

Authors:  Dayna R Cenin; Steffie K Naber; Anne C de Weerdt; Mark A Jenkins; David B Preen; Hooi C Ee; Peter C O'Leary; Iris Lansdorp-Vogelaar
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-11-20       Impact factor: 4.254

3.  An evaluation of treatment results of emergency versus elective surgery in colorectal cancer patients.

Authors:  Bahattin Bayar; Kerim Bora Yılmaz; Melih Akıncı; Alpaslan Şahin; Hakan Kulaçoğlu
Journal:  Ulus Cerrahi Derg       Date:  2015-08-18

Review 4.  Colorectal cancer screening in countries of European Council outside of the EU-28.

Authors:  Emma Altobelli; Francesco D'Aloisio; Paolo Matteo Angeletti
Journal:  World J Gastroenterol       Date:  2016-05-28       Impact factor: 5.742

5.  MicroRNA-184 inhibits cell proliferation and metastasis in human colorectal cancer by directly targeting IGF-1R.

Authors:  Guannan Wu; Jiayun Liu; Zhenfeng Wu; Xiaoyu Wu; Xuequan Yao
Journal:  Oncol Lett       Date:  2017-06-30       Impact factor: 2.967

6.  Colon Cancer Screening Programs: Impact of an Organized Screening Strategy Assessed by the EDIFICE Surveys.

Authors:  Jérôme Viguier; Jean-François Morère; Lysel Brignoli-Guibaudet; Christine Lhomel; Sébastien Couraud; François Eisinger
Journal:  Curr Oncol Rep       Date:  2018-03-05       Impact factor: 5.075

7.  Family Physicians' Knowledge, Attitudes, and Practices Toward Colorectal Cancer Screening.

Authors:  Mustafa Kürşat Şahin; Servet Aker
Journal:  J Cancer Educ       Date:  2017-12       Impact factor: 2.037

8.  Utility of the Asia-Pacific colorectal screening scoring system and the presence of metabolic syndrome components in screening for sporadic colorectal cancer.

Authors:  Jiang-Yuan Wang; Zhen-Tao Li; Yuan-Min Zhu; Wen-Chao Wang; Yan Ma; Yu-Lan Liu
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

Review 9.  Stool DNA methylation assays in colorectal cancer screening.

Authors:  Tanya Kadiyska; Alexander Nossikoff
Journal:  World J Gastroenterol       Date:  2015-09-21       Impact factor: 5.742

10.  The education gradient in cancer screening participation: a consistent phenomenon across Europe?

Authors:  Barbara Willems; Piet Bracke
Journal:  Int J Public Health       Date:  2017-10-23       Impact factor: 3.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.